乾癬性関節炎治療薬の世界市場（～2026年）

• 英文タイトル：Global Psoriatic Arthritis Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04407
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は乾癬性関節炎治療薬のグローバル市場について調査・分析したレポートです。種類別（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤）市場規模、用途別（病院、診療所、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別乾癬性関節炎治療薬の競争状況、市場シェア
・世界の乾癬性関節炎治療薬市場：種類別市場規模 2015年-2020年（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤）
・世界の乾癬性関節炎治療薬市場：種類別市場規模予測 2021年-2026年（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤）
・世界の乾癬性関節炎治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、研究所）
・世界の乾癬性関節炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究所）
・北米の乾癬性関節炎治療薬市場分析：米国、カナダ
・ヨーロッパの乾癬性関節炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの乾癬性関節炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の乾癬性関節炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの乾癬性関節炎治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Bayer、Novartis、Abbott Laboratories、Sanofi、Bristol-Myers Squibb、Janssen Biotech、Amgen、UCB、AbbVie
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis.

Market Analysis and Insights: Global Psoriatic Arthritis Therapeutics Market
The global Psoriatic Arthritis Therapeutics market size is projected to reach US$ 7019.3 million by 2026, from US$ 6400 million in 2020, at a CAGR of 9.0%% during 2021-2026.

Global Psoriatic Arthritis Therapeutics Scope and Market Size
Psoriatic Arthritis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Bayer
Novartis
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Janssen Biotech
Amgen
UCB
AbbVie

Market segment by Type, the product can be split into
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor
Market segment by Application, split into
Hospitals
Clinics
Research Labs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriatic Arthritis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nonsteroidal Anti-Inflammatory Drug
1.4.3 Disease-Modifying Antirheumatic Drug
1.4.4 Biologic Drug
1.4.5 Enzyme Inhibitor
1.5 Market by Application
1.5.1 Global Psoriatic Arthritis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Labs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Psoriatic Arthritis Therapeutics Market Perspective (2015-2026)
2.2 Global Psoriatic Arthritis Therapeutics Growth Trends by Regions
2.2.1 Psoriatic Arthritis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psoriatic Arthritis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Psoriatic Arthritis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Psoriatic Arthritis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Psoriatic Arthritis Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Therapeutics Players by Market Size
3.1.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio
3.2.1 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Revenue in 2019
3.3 Psoriatic Arthritis Therapeutics Key Players Head office and Area Served
3.4 Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
3.5 Date of Enter into Psoriatic Arthritis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)
5.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Psoriatic Arthritis Therapeutics Market Size (2015-2020)
6.2 Psoriatic Arthritis Therapeutics Key Players in North America (2019-2020)
6.3 North America Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
6.4 North America Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Market Size (2015-2020)
7.2 Psoriatic Arthritis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Psoriatic Arthritis Therapeutics Market Size (2015-2020)
8.2 Psoriatic Arthritis Therapeutics Key Players in China (2019-2020)
8.3 China Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
8.4 China Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Psoriatic Arthritis Therapeutics Market Size (2015-2020)
9.2 Psoriatic Arthritis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Psoriatic Arthritis Therapeutics Market Size (2015-2020)
10.2 Psoriatic Arthritis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Psoriatic Arthritis Therapeutics Market Size (2015-2020)
11.2 Psoriatic Arthritis Therapeutics Key Players in India (2019-2020)
11.3 India Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
11.4 India Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Psoriatic Arthritis Therapeutics Market Size (2015-2020)
12.2 Psoriatic Arthritis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Psoriatic Arthritis Therapeutics Introduction
13.1.4 Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Psoriatic Arthritis Therapeutics Introduction
13.2.4 Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Psoriatic Arthritis Therapeutics Introduction
13.3.4 Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Introduction
13.4.4 Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Psoriatic Arthritis Therapeutics Introduction
13.5.4 Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Introduction
13.6.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Janssen Biotech
13.7.1 Janssen Biotech Company Details
13.7.2 Janssen Biotech Business Overview
13.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Introduction
13.7.4 Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.7.5 Janssen Biotech Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview
13.8.3 Amgen Psoriatic Arthritis Therapeutics Introduction
13.8.4 Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 UCB
13.9.1 UCB Company Details
13.9.2 UCB Business Overview
13.9.3 UCB Psoriatic Arthritis Therapeutics Introduction
13.9.4 UCB Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.9.5 UCB Recent Development
13.10 AbbVie
13.10.1 AbbVie Company Details
13.10.2 AbbVie Business Overview
13.10.3 AbbVie Psoriatic Arthritis Therapeutics Introduction
13.10.4 AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
13.10.5 AbbVie Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Psoriatic Arthritis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Psoriatic Arthritis Therapeutics Revenue
Table 3. Ranking of Global Top Psoriatic Arthritis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nonsteroidal Anti-Inflammatory Drug
Table 6. Key Players of Disease-Modifying Antirheumatic Drug
Table 7. Key Players of Biologic Drug
Table 8. Key Players of Enzyme Inhibitor
Table 9. Global Psoriatic Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Psoriatic Arthritis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Psoriatic Arthritis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Psoriatic Arthritis Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Psoriatic Arthritis Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Psoriatic Arthritis Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Psoriatic Arthritis Therapeutics Players
Table 20. Global Psoriatic Arthritis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Psoriatic Arthritis Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2019)
Table 23. Global Psoriatic Arthritis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
Table 26. Date of Enter into Psoriatic Arthritis Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Psoriatic Arthritis Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Psoriatic Arthritis Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Psoriatic Arthritis Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 36. North America Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 38. North America Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 42. Europe Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 48. China Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 50. China Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 54. Japan Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 66. India Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 68. India Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Psoriatic Arthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Psoriatic Arthritis Therapeutics Market Share (2019-2020)
Table 72. Central & South America Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Psoriatic Arthritis Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Psoriatic Arthritis Therapeutics Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Product
Table 84. Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 85. Bayer Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Abbott Laboratories Company Details
Table 92. Abbott Laboratories Business Overview
Table 93. Abbott Laboratories Product
Table 94. Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 95. Abbott Laboratories Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Product
Table 99. Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 100. Sanofi Recent Development
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Janssen Biotech Company Details
Table 107. Janssen Biotech Business Overview
Table 108. Janssen Biotech Product
Table 109. Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 110. Janssen Biotech Recent Development
Table 111. Amgen Business Overview
Table 112. Amgen Product
Table 113. Amgen Company Details
Table 114. Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 115. Amgen Recent Development
Table 116. UCB Company Details
Table 117. UCB Business Overview
Table 118. UCB Product
Table 119. UCB Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 120. UCB Recent Development
Table 121. AbbVie Company Details
Table 122. AbbVie Business Overview
Table 123. AbbVie Product
Table 124. AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020) (Million US$)
Table 125. AbbVie Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriatic Arthritis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Nonsteroidal Anti-Inflammatory Drug Features
Figure 3. Disease-Modifying Antirheumatic Drug Features
Figure 4. Biologic Drug Features
Figure 5. Enzyme Inhibitor Features
Figure 6. Global Psoriatic Arthritis Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Labs Case Studies
Figure 10. Psoriatic Arthritis Therapeutics Report Years Considered
Figure 11. Global Psoriatic Arthritis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Psoriatic Arthritis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Psoriatic Arthritis Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Psoriatic Arthritis Therapeutics Market Share by Players in 2019
Figure 16. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Revenue in 2019
Figure 18. North America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

乾癬性関節炎治療の世界市場（～2026年）

Global Psoriatic Arthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04408 2020年11月20日 95Pages
当調査資料は乾癬性関節炎治療のグローバル市場について調査・分析したレポートです。種類別（キット、試薬、器具）市場規模、用途別（病院、診療所、外来手術センター、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

敗血症性関節炎の世界市場（～2026年）

Global Septic Arthritis Market Size, Status and Forecast 2020-2026
MRC2-11QY04586 2020年11月20日 97Pages
当調査資料は敗血症性関節炎のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（整形外科病院、クリニック、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

関節リウマチ治療の世界市場（～2026年）

Global Rheumatoid Arthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04516 2020年11月20日 99Pages
当調査資料は関節リウマチ治療のグローバル市場について調査・分析したレポートです。種類別（対症療法、中間コルチコステロイド療法、疾患修飾性抗リウマチ薬療法）市場規模、用途別（病院薬局、小売薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

全身性特発性若年性関節炎治療の世界市場（～2026年）

Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04784 2020年11月20日 92Pages
当調査資料は全身性特発性若年性関節炎治療のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

関節リウマチ診断検査の世界市場（～2026年）

Global Rheumatoid Arthritis Diagnosis Tests Market Size, Status and Forecast 2020-2026
MRC2-11QY04515 2020年11月20日 90Pages
当調査資料は関節リウマチ診断検査のグローバル市場について調査・分析したレポートです。種類別（血清学検査、RA治療効率検査モニタリング）市場規模、用途別（診断研究所、外来外科センター、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

関節炎薬の世界市場（～2026年）

Global Arthritis Drug Market Insights and Forecast to 2026
MRC2-11QY02683 2020年11月20日 112Pages
当調査資料は関節炎薬のグローバル市場について調査・分析したレポートです。種類別（合成DMARD、生物学的DMARD、NSAID、コルチコステロイド、鎮痛薬）市場規模、用途別（小売薬局、病院薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

関節リウマチ治療薬の世界市場（～2026年）

Global Rheumatoid Arthritis Drugs Market Insights and Forecast to 2026
MRC2-11QY09117 2020年11月25日 114Pages
当調査資料は関節リウマチ治療薬のグローバル市場について調査・分析したレポートです。種類別（処方薬、市販薬）市場規模、用途別（病院、クリニック、老人ホーム、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

多関節若年性特発性関節炎治療薬の世界市場（～2026年）

Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Insights and Forecast to 2026
MRC2-11QY13950 2020年11月30日 111Pages
当調査資料は多関節若年性特発性関節炎治療薬のグローバル市場について調査・分析したレポートです。種類別（エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ド...

血清反応陽性用関節リウマチ治療薬の世界市場（～2026年）

Global Seropositive Rheumatoid Arthritis Drug Market Insights and Forecast to 2026
MRC2-11QY09391 2020年11月25日 152Pages
当調査資料は血清反応陽性用関節リウマチ治療薬のグローバル市場について調査・分析したレポートです。種類別（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ治療薬、生物製剤）市場規模、用途別（医療、科学研究、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

生物学的治療の世界市場（～2026年）

Global Biologic Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11070 2020年11月25日 99Pages
当調査資料は生物学的治療のグローバル市場について調査・分析したレポートです。種類別（ワクチン、血液製剤、アレルゲン抽出物、ヒト細胞・組織、遺伝子治療、タンパク質、細胞治療、異種移植製品）市場規模、用途別（関節リウマチ、貧血、がん、糖尿病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイ...

乾癬性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Psoriatic Arthritis Treatment Market The global Psoriatic Arthritis Treatment market size is projected to reach US$ 8155.4 million by 2026, from US$ 7679.9 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Psoriatic Arthritis Treatment Scope and Market…
関節炎薬の世界市場（～2026年） Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoart…
関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
多関節若年性特発性関節炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Polyarticular Juvenile Idiopathic Arthritis Drug Market The global Polyarticular Juvenile Idiopathic Arthritis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Polyarticular Juv…
血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…